VNDA
Vanda Pharmaceuticals Inc
5.20$
+0.5%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -165.1% | – | – | +53.2% | +12.7% | +24.0% | -50.2% | -60.0% | -223.1% | – | |
| – | +386.9% | -12.4% | -74.9% | -0.9% | -2.2% | -1.0% | -0.8% | -3.8% | +10.1% | +170.2% | -111.7% | |
| – | +35.4% | +7.3% | +22.5% | +11.5% | +15.4% | -0.7% | +15.1% | +5.9% | -13.8% | -11.5% | -23.8% | |
| – | – | +5.4% | +21.7% | +7.1% | -712.9% | – | +11.9% | -16.7% | – | – | – | |
| – | – | -137.7% | – | – | – | +38.1% | -36.6% | +121.9% | -112.3% | – | – | |
| – | -71.2% | -44.3% | +18.3% | +1,424.5% | -96.0% | +76.2% | -69.2% | +23.0% | -43.6% | +27.9% | +103.7% | |
| – | +121.0% | -62.1% | +0.4% | +985.0% | -37.7% | -39.2% | +84.8% | – | -124.1% | +44.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.4% | – | -32.3% | +1,940.1% | -94.2% | -10.1% | -37.0% | -79.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +1,184.5% | |
| – | -95.4% | +89.5% | -32.3% | +1,940.1% | -94.2% | -10.1% | -37.0% | -79.3% | -17.6% | -125.6% | +1,774.8% | |
| – | – | – | – | – | -158.5% | – | -156.3% | – | -99.0% | -4,330.4% | – | |
| – | – | -195.8% | – | – | +872.9% | +11.2% | +27.4% | -50.8% | -60.3% | -230.8% | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.